[Antidiabetic therapy in diabetic patients with coronary heart disease].
D000284:Administration, Oral; D003327:Coronary Disease / Q000150:complications* / Q000378:metabolism; D003692:Delayed-Action Preparations / Q000008:administration & dosage; D048909:Diabetes Complications; D003920:Diabetes Mellitus / Q000188:drug therapy* / Q000378:metabolism; D003925:Diabetic Angiopathies / Q000188:drug therapy / Q000378:metabolism; D004334:Drug Administration Schedule; D005905:Glyburide / Q000627:therapeutic use; D006801:Humans; D006943:Hyperglycemia / Q000188:drug therapy* / Q000209:etiology; D007004:Hypoglycemic Agents / Q000008:administration & dosage*; D007328:Insulin / Q000008:administration & dosage* / Q000031:analogs & derivatives* / Q000627:therapeutic use; D000069036:Insulin Glargine; D049528:Insulin, Long-Acting; D011379:Prognosis; D016032:Randomized Controlled Trials as Topic
D003692:Delayed-Action Preparations; D007004:Hypoglycemic Agents; D007328:Insulin; D049528:Insulin, Long-Acting; D000069036:Insulin Glargine; D005905:Glyburide
La terapia antidiabetica del diabetico coronaropatico.